To the Editor: Dr Natanson and colleagues1 published a meta-analysis attempting to compare the safety profile for 5 different HBOCs. They pooled adverse event data for MI and death from 16 diverse trials conducted from 1997 to 2007, with study populations ranging from 10 to more than 700 patients in a variety of cardiac, orthopedic, vascular, ischemic stroke, and trauma patient populations. The majority of data came from earlier generation products, including HemAssist (Baxter Healthcare, Deerfield, Illinois) and Hemolink (Hemosol Inc, Mississauga, Ontario, Canada), which were discontinued in 1998 and in 2004, respectively; Hemopure (Biopure); and PolyHeme (Northfield Laboratories, Evanston, Illinois). The pooled analysis concluded that HBOCs were associated with a significantly increased risk of death and MI.
Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more
Subscribe for full-text access to content from 1998 forward and a host of useful features
Activate your current subscription (AMA members and current subscribers)
Purchase Online Access to this article for 24 hours
Country-Specific Mortality and Growth Failure in Infancy and Yound Children and Association With Material Stature
Use interactive graphics and maps to view and sort country-specific infant and early dhildhood mortality and growth failure data and their association with maternal
Some tools below are only available to our subscribers or users with an online account.
Download citation file:
Web of Science® Times Cited: 8
Customize your page view by dragging & repositioning the boxes below.
More Listings atJAMACareerCenter.com >
and access these and other features:
Enter your username and email address. We'll send you a link to reset your password.
Enter your username and email address. We'll send instructions on how to reset your password to the email address we have on record.
Athens and Shibboleth are access management services that provide single sign-on to protected resources. They replace the multiple user names and passwords necessary to access subscription-based content with a single user name and password that can be entered once per session. It operates independently of a user's location or IP address. If your institution uses Athens or Shibboleth authentication, please contact your site administrator to receive your user name and password.